全文获取类型
收费全文 | 6325篇 |
免费 | 373篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 34篇 |
儿科学 | 179篇 |
妇产科学 | 79篇 |
基础医学 | 1038篇 |
口腔科学 | 149篇 |
临床医学 | 406篇 |
内科学 | 1485篇 |
皮肤病学 | 229篇 |
神经病学 | 552篇 |
特种医学 | 272篇 |
外国民族医学 | 1篇 |
外科学 | 696篇 |
综合类 | 17篇 |
预防医学 | 308篇 |
眼科学 | 220篇 |
药学 | 455篇 |
中国医学 | 20篇 |
肿瘤学 | 602篇 |
出版年
2023年 | 51篇 |
2022年 | 114篇 |
2021年 | 186篇 |
2020年 | 89篇 |
2019年 | 95篇 |
2018年 | 167篇 |
2017年 | 141篇 |
2016年 | 151篇 |
2015年 | 158篇 |
2014年 | 244篇 |
2013年 | 250篇 |
2012年 | 368篇 |
2011年 | 464篇 |
2010年 | 275篇 |
2009年 | 224篇 |
2008年 | 417篇 |
2007年 | 440篇 |
2006年 | 419篇 |
2005年 | 451篇 |
2004年 | 367篇 |
2003年 | 361篇 |
2002年 | 367篇 |
2001年 | 61篇 |
2000年 | 43篇 |
1999年 | 72篇 |
1998年 | 63篇 |
1997年 | 49篇 |
1996年 | 45篇 |
1995年 | 40篇 |
1994年 | 50篇 |
1993年 | 30篇 |
1992年 | 34篇 |
1991年 | 36篇 |
1990年 | 27篇 |
1989年 | 36篇 |
1988年 | 28篇 |
1987年 | 25篇 |
1986年 | 32篇 |
1985年 | 28篇 |
1984年 | 21篇 |
1983年 | 18篇 |
1982年 | 17篇 |
1981年 | 11篇 |
1979年 | 14篇 |
1978年 | 17篇 |
1976年 | 12篇 |
1974年 | 13篇 |
1971年 | 14篇 |
1969年 | 11篇 |
1965年 | 9篇 |
排序方式: 共有6742条查询结果,搜索用时 15 毫秒
991.
PURPOSE: To evaluate the function status of TB advisory committee to assess treatments of tuberculosis. OBJECT AND METHOD: Estimate by questionnaire sheets to public health nurses attending to seminars on tuberculosis at Research Institute of Tuberculosis. RESULT: 137 answers are available for analysis. Of these, 57 (41.6%) TB advisory committees are estimated not to assess treatments of tuberculosis at all and/or to assess treatments without necessary informations on drug sensitivity in more than around half of the cases. In 13 (16.3%) committees of the other 80, many cases are in fact self-assessed. Number of committees that are estimated to functioning well is only 44 (32.1%). CONCLUSION: Many TB advisory committees are estimated to be malfunctioning from the stand point of assessments of treatment. As TB advisory committee is one of key agency to control drug-resistant tuberculosis, its reform and revitalization are urgently needed. 相似文献
992.
Takashi Shiihara Taeko Miyake Sakiko Izumi Mio Watanabe Keiko Kamayachi Kazuhiko Kodama Makoto Nabetani Masako Ikemiyagi Yoshio Yamaguchi Noriko Sawaura 《Pediatrics international》2012,54(1):52-55
Background: Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is characterized clinically by biphasic seizures and late magnetic resonance imaging abnormalities, such as reduced subcortical diffusion from day 3 onwards, often accompanied with some neurological sequelae. In the early stages of the disease, AESD closely resembles its far more prevalent and relatively benign counterpart, febrile seizure (FS). Methods: We measured and compared the serum or cerebrospinal fluid (CSF) levels of S100B, neuron‐specific enolase (NSE), and total tau protein in 43 patients with FS and 18 patients with AESD, at any point during the disease. To assess early diagnostic validity, we compared these biomarkers in 43 FS and eight AESD patients, with whom the day 0–2 samples were available. We used the receiver–operator characteristic curve to evaluate the diagnostic values of these markers. Results: The levels of all biomarkers were significantly higher in AESD than FS patients. When only day 0–2 samples from AESD patients were used, the levels of all the measured biomarkers, except serum NSE, were still significantly higher in patients with AESD than in FS, suggesting that AESD could damage astrocytes, neurons, and axons, even in the early stages of the disease. According to the receiver–operator characteristic curve analyses, CSF S100B (cut‐off value, 100 pg/mL) and CSF total tau protein (cut‐off value, 100 pg/mL) were better predictors of AESD than other biomarkers. Conclusion: The combination of CSF S100B and CSF total tau protein resulted in a positive predictive value of AESD 83.3%, which could be helpful for early diagnosis, facilitating early therapeutic interventions. 相似文献
993.
Noriko Kishida Seiichiro Fujisaki Masaru Yokoyama Hironori Sato Reiko Saito Hideyuki Ikematsu Hong Xu Emi Takashita Masato Tashiro Shinichi Takao Takuya Yano Tomoko Suga Chiharu Kawakami Miwako Yamamoto Keiko Kajiyama Hiroyuki Saito Shin'ichi Shimada Sumi Watanabe Satomi Aoki Katsuya Taira Miyako Kon Jih-Hui Lin Takato Odagiri 《Clinical and Vaccine Immunology : CVI》2012,19(6):897-908
The vaccine strains against influenza virus A/H3N2 for the 2010-2011 season and influenza virus B for the 2009-2010 and 2010-2011 seasons in Japan are a high-growth reassortant A/Victoria/210/2009 (X-187) strain and an egg-adapted B/Brisbane/60/2008 (Victoria lineage) strain, respectively. Hemagglutination inhibition (HI) tests with postinfection ferret antisera indicated that the antisera raised against the X-187 and egg-adapted B/Brisbane/60/2008 vaccine production strains poorly inhibited recent epidemic isolates of MDCK-grown A/H3N2 and B/Victoria lineage viruses, respectively. The low reactivity of the ferret antisera may be attributable to changes in the hemagglutinin (HA) protein of production strains during egg adaptation. To evaluate the efficacy of A/H3N2 and B vaccines, the cross-reactivities of postvaccination human serum antibodies against A/H3N2 and B/Victoria lineage epidemic isolates were assessed by a comparison of the geometric mean titers (GMTs) of HI and neutralization (NT) tests. Serum antibodies elicited by the X-187 vaccine had low cross-reactivity to both MDCK- and egg-grown A/H3N2 isolates by HI test and narrow cross-reactivity by NT test in all age groups. On the other hand, the GMTs to B viruses detected by HI test were below the marginal level, so the cross-reactivity was assessed by NT test. The serum neutralizing antibodies elicited by the B/Brisbane/60/2008 vaccine reacted well with egg-grown B viruses but exhibited remarkably low reactivity to MDCK-grown B viruses. The results of these human serological studies suggest that the influenza A/H3N2 vaccine for the 2010-2011 season and B vaccine for the 2009-2010 and 2010-2011 seasons may possess insufficient efficacy and low efficacy, respectively. 相似文献
994.
995.
Nakai M Hashikura Y Ohkouchi M Yamamura M Akiyama T Shiba K Kajimoto N Tsukamoto Y Hao H Isozaki K Hirai T Hirota S 《Laboratory investigation; a journal of technical methods and pathology》2012,92(3):451-457
We found a novel type germline mutation at exon 11 of the c-kit gene, which results in a substitution of Tyr to Cys at codon 553 of the c-kit gene product (KIT-Tyr553Cys), in a 68-year-old female patient with multiple gastrointestinal stromal tumors (GISTs). In the present study, we carried out mutational analysis in her family members to determine the carriers and characterized the mutation by introducing the corresponding mutation (murine KIT-Tyr552Cys) into expression vector possessing murine c-kit cDNA. Mutational analysis of peripheral blood leukocytes of her family members revealed that a 44-year-old son had the same mutation, but at present he had neither apparent symptoms nor images of multiple GISTs. By transfection with the expression vector possessing the murine mutant c-kit cDNA, interleukin-3-dependent Ba/F3 murine lymphoid cells started growing autonomously without any growth factors, indicating that the mutation was considered to be of gain-of-function. Imatinib, a small molecule of tyrosine kinase inhibitor, effectively inhibited autophosphorylation of KIT-Tyr552Cys. Nilotinib, another small molecule of the KIT inhibitor, also effectively inhibited autophosphorylation of KIT-Tyr552Cys. In fact, proliferation of Ba/F3 cells expressing KIT-Tyr552Cys was effectively inhibited by both imatinib and nilotinib. These findings indicate that the novel type human KIT-Tyr553Cys mutation is the cause of the present familial and multiple GISTs, and that both imatinib and nilotinib might effectively inhibit the growth of GISTs developing in the patients of this family. 相似文献
996.
997.
998.
999.